Stock listing
Eikon Therapeutics, Inc.
Selected listing: EIKN · BX · CHF · CH
Eikon Therapeutics, Inc. (BX Swiss: EIKN), Health Technology. Latest release Sep 3, 2026: Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D.…
- Ticker
- BX Swiss: EIKN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX Swiss
- Currency
- CHF
About Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. is a public company traded under the ticker EIKN in the American market. Eikon focuses on developing innovative therapeutic solutions, leveraging advanced technologies to address unmet medical needs.
Latest news from Eikon Therapeutics, Inc.
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
September 3, 2026
Eikon Therapeutics to Participate in Investor Conferences in September 2026
August 26, 2026
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
August 18, 2026
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 13, 2026
Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma
August 11, 2026
Research Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. company profile
View the public company page for Eikon Therapeutics, Inc. on 6ix.
Eikon Therapeutics, Inc. news
Read company news and market updates connected to Eikon Therapeutics, Inc..
Eikon Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Eikon Therapeutics, Inc..